Bharat Parenterals Ltd — Important, 12-11-2025: Company Update

Bharat Parenterals Limited's Board has adopted a revised Code of Conduct for Preventing Insider Trading. Alongside this, a new Code of Corporate Disclosure Practices was approved, which includes a policy on determining 'Legitimate Purpose.' This proactive measure significantly strengthens the company's commitment to robust corporate governance and enhances transparency. It ensures stricter internal controls over sensitive information and promotes fair dealing, which is crucial for maintaining market integrity and boosting investor confidence in the company's ethical standards.